©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 109395
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.109395
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.109395
Table 3 Short-term postoperative outcomes, mean ± SD/median (25th-75th percentiles)
| Characteristic | Overall | HALS | CLS | RAS | P value | SMD |
| n | 224 | 35 | 95 | 94 | ||
| Duration of surgery (min) | 177.81 ± 43.04 | 175.23 ± 36.29 | 184.10 ± 42.83 | 172.42 ± 45.12 | 0.166 | 0.186 |
| Amount of bleeding (mL) | 160.86 ± 132.90 | 123.71 ± 71.54 | 162.71 ± 106.99 | 172.96 ± 168.19 | 0.172 | 0.294 |
| Number of lymph nodes cleared | 15.00 (11.00–20.00) | 17.00 (12.00–21.00) | 15.00 (12.00–19.50) | 15.00 (10.00–20.00) | 0.478 | 0.213 |
| D1.WC (× 109/L) | 9.15 (7.36–11.23) | 7.86 (6.30–10.66) | 9.47 (7.90–11.07) | 9.16 (7.11–11.60) | 0.203 | 0.246 |
| D1.NE (× 109/L) | 7.70 (6.06–9.68) | 6.30 (4.77–9.51) | 7.66 (6.46–9.49) | 8.02 (6.15–10.22) | 0.210 | 0.259 |
| D1.LYM (× 109/L) | 0.73 (0.53–0.97) | 0.74 (0.48–0.92) | 0.76 (0.58–1.04) | 0.67 (0.53–0.94) | 0.247 | 0.241 |
| D1.CRP (× 109/L) | 41.23 (22.65–69.74) | 48.72 (24.92–74.72) | 42.17 (25.84–71.86) | 30.82 (13.54–57.68) | 0.348 | 0.153 |
| D4.WC (× 109/L) | 6.66 (5.58–8.25) | 5.76 (5.03–7.52) | 6.58 (5.47–7.98) | 7.27 (6.23–9.44) | 0.003 | 0.427 |
| D4.NE (× 109/L) | 5.17 (3.98–6.46) | 4.43 (3.27–5.78) | 5.03 (3.78–6.06) | 5.67 (4.74–7.72) | 0.002 | 0.309 |
| D4.LYM (× 109/L) | 0.86 (0.64–1.13) | 0.83 (0.66–0.99) | 0.92 (0.69–1.22) | 0.81 (0.60–1.04) | 0.109 | 0.255 |
| D4.CRP (mg/L) | 68.57 ± 38.05 | 80.11 ± 42.04 | 59.35 ± 37.05 | 76.31 ± 34.61 | 0.084 | 0.365 |
| Length of postoperative hospital stay (days) | 8.00 (7.00–10.00) | 7.00 (6.00–8.00) | 9.00 (8.00–11.00) | 8.00 (7.00–10.00) | < 0.001 | 0.444 |
| Postoperative recovery time of gastrointestinal function (days) | 5.00 (4.00–6.00) | 4.00 (3.00–5.00) | 5.00 (4.50–6.00) | 5.00 (4.00–6.00) | < 0.001 | 0.597 |
| Duration of postoperative use of pain medication (days) | 4.00 (3.00–5.00) | 4.00 (3.00–5.00) | 4.00 (3.00–5.00) | 4.00 (3.00–5.00) | 0.248 | 0.155 |
| Hospitalization costs (USD) | 8987.40 ± 2318.62 | 8214.99 ± 1584.15 | 8534.28 ± 1513.88 | 9723.30 ± 2934.85 | <0.001 | 0.452 |
- Citation: Chen H, Han DP, Xiong JY, Li ZS, Hu TC, Li ZR, Cao Y. Comparative clinical efficacy of three surgical modalities for the treatment of malignant tumours of the left hemicolon. World J Gastrointest Surg 2025; 17(10): 109395
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/109395.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.109395